Viewing Study NCT03425461


Ignite Creation Date: 2025-12-24 @ 12:07 PM
Ignite Modification Date: 2025-12-28 @ 12:46 PM
Study NCT ID: NCT03425461
Status: TERMINATED
Last Update Posted: 2021-04-02
First Post: 2018-01-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma
Sponsor: Jonsson Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module